Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 7 results when searching "Guselkumab"

DOCUMENT

13/05/2026 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 13 May 2026 Page 1 of 15 East Region Formulary Committee Minutes Date: 13 May 2026 Time: 2.00pm – 4:20pm Location: MS Teams Present: Mona Boriceanu Advanced N...

DOCUMENT

12/11/2025 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 12 November 2025 Page 1 of 10 East Region Formulary Committee Minutes Date: 12 November 2025 Time: 2.00pm – 4:00pm Location: MS Teams Present: Malcolm Clubb ...

DOCUMENT

24/11/2021 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 24 November 2021 Page 1 of 24 East Region Formulary Committee Minutes Date: 24 November 2021 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning Lead P...

FORMULARY DECISION

Guselkumab : Tremfya

SMC2848 : Treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy, ...

FORMULARY DECISION

Guselkumab : Tremfya

SMC2850 : For the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response, or were intolerant to either conventional therapy o...

FORMULARY DECISION

Guselkumab : Tremfya

1340/18 : Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy

FORMULARY DECISION

Guselkumab : Tremfya

SMC2360 : Alone or in combination with methotrexate (MTX) for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior d...